Skip to Main Content

Paper Details

Real-Life Experience on Dolutegravir and Lamivudine as Initial or Switch Therapy in a Silver Population Living with HIV.
Viruses
3
2023
Author NameAffiliation
Maria MazzitelliPadua University Hospital
  • 1 - 1

Datasets

Release 1.2